When Time’s on Your Side: Aligning Cancer Therapy with the Body’s Clock
Emerging evidence suggests that our internal 24-hour rhythm does more than regulate sleep it may hold the key to enhancing cancer treatments. Researchers at Johns Hopkins University are exploring how leveraging the body’s circadian clock could transform how, when, and why certain therapies succeed.
The Body’s Clock Meets Cancer
Every cell in our body follows a rhythm set by the master pacemaker in the brain, which governs sleep-wake cycles, metabolism, hormone production, and immune responses. Disruptions to this rhythm—such as from night shift work—have been linked to heightened disease risk, including cancer.
Chi Van Dang, Bloomberg Distinguished Professor of Cancer Medicine, has been investigating how cancer cells may hijack this internal timing system, especially via the oncogene MYC, which appears to overlap with circadian clock gene networks.
Timing Is Everything: Therapy at the Right Hour
The idea is simple yet profound: if cell processes ebb and flow across the day, then treatments given at optimal times might be more effective or less toxic. For example:
-
Some chemotherapy regimens show better results when administered at particular times of day.
-
Immunotherapy appears more effective when given in the morning—immune "killer" lymphocytes enter tumors more actively earlier in the day.
Such findings raise the possibility that “when” a drug is given might matter as much as “which” drug.
Practical Hurdles and Promising Workarounds
Translating circadian-based treatment into routine clinics presents real challenges: hospitals can’t always schedule all therapies at the most favorable hour. Researchers are exploring alternatives like:
-
Adjusting patients’ internal clocks via diet, mealtimes, or light exposure.
-
Offering sophisticated therapies in outpatient or home settings so timing is more flexible.
While more studies are needed, the concept opens new routes for tailoring when therapies are delivered.
Beyond Cancer: A Wider Timing Frontier
Timing matters not only for cancer but for many medications. For instance, some heart medications work more effectively when taken at night; certain cholesterol drugs have optimal nighttime effects because of enzyme cycles. This broadens the impact of circadian medicine from cancer care into general pharmacotherapy.
Looking Ahead: What’s Next in Circadian Oncology
Dang and his team are investigating how circadian disruption in different tumor types affects growth, and how diet (such as time-restricted feeding) might reset clocks and improve therapy response. Importantly, tumor-type specificity matters: some cancers may respond differently to clock disruption.
As the research progresses, experts say medical education, pharmaceutical development, and clinical practice all need to integrate circadian awareness to optimize treatments.
Read the full article here.
